Skip to main content
Concord Biotech Limited logo

Concord Biotech Limited — Investor Relations & Filings

Ticker · CONCORDBIO ISIN · INE338H01029 LEI · 335800FBIZZTLAXLXZ73 BSE.NS Manufacturing
Open in API
Filings indexed 225 across all filing types
Latest filing 2025-09-09 AGM Information
Country IN India
Listing BSE.NS CONCORDBIO

About Concord Biotech Limited

https://concordbiotech.com/

Concord Biotech Limited is a research and development-driven company specializing in the production of fermentation-based Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization focuses on niche therapeutic areas, including immunosuppressants, oncology, anti-fungals, and anti-infectives. It maintains a significant global presence, supplying products to regulated markets such as the United States, Europe, and Japan. Concord Biotech operates large-scale fermentation facilities and is recognized for its expertise in complex manufacturing processes. Its operations are vertically integrated, covering the entire value chain from strain development and fermentation to downstream processing and formulation. The company adheres to international quality standards, holding certifications from major regulatory bodies like the USFDA and EUGMP, ensuring the delivery of high-quality pharmaceutical solutions to its global clientele.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed summary of the proceedings of the 40th Annual General Meeting (AGM) of Concord Biotech Limited held on September 9, 2025. It includes information about the meeting logistics, attendance, chairman's speech overviewing financial performance, voting procedures, and next steps for voting results. The document references compliance with SEBI Listing Regulations and the Companies Act, 2013. It is not the full Annual Report or financial statements but a summary of the AGM proceedings. The document length is about 9000 characters, which is substantial but the content clearly matches the description of AGM Information filings, which include presentations and materials shared during the AGM. Therefore, the correct classification is AGM Information (AGM-R).
2025-09-09 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal announcement addressed to stock exchanges regarding the completion of a European Union Good Manufacturing Practices (EU GMP) inspection at the company's API facility. It references a regulatory disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to material event disclosures. The document does not contain financial statements, audit information, or detailed report data. It is a regulatory announcement about a compliance milestone rather than a financial or management report. The document length is short (2402 characters), and it serves as an informational update to the market rather than a report or filing of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q1 FY26 earnings conference call held on August 11, 2025, by Concord Biotech Limited. It includes opening remarks by the Chairman and Managing Director, the Joint Managing Director and CEO, and the CFO, discussing quarterly financial results, business performance, regulatory approvals, and strategic initiatives. The text contains actual financial data such as revenues, EBITDA, segmental performance, and outlook. The presence of a Q&A session is implied by the conference call format. The document is not merely an announcement or a brief summary but a full transcript of the earnings call. Therefore, the appropriate classification is Call Transcript (CT).
2025-08-18 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter dated August 14, 2025, from Concord Biotech Limited addressed to the National Stock Exchange of India and BSE Limited. It announces the publication of a newspaper advertisement regarding the 40th Annual General Meeting (AGM) scheduled for September 9, 2025, including e-voting information and record date for dividend. The letter encloses copies of the newspaper advertisement and states that the information is for records. There is no detailed financial data, management discussion, or report content; rather, it is an announcement about the AGM and related voting information. The document is about the AGM event notification and voting information dissemination, which fits the category of AGM Information (AGM-R). The document length is 15,000 characters, but the content is primarily an announcement of the AGM and voting details, not the AGM materials themselves or the results. Therefore, the correct classification is AGM Information (AGM-R).
2025-08-14 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed notice for the 40th Annual General Meeting (AGM) of Concord Biotech Limited, scheduled for 9th September 2025. It includes agenda items such as adoption of audited standalone and consolidated financial statements for the fiscal year ended 31st March 2025, declaration of dividend, appointment of directors, ratification of remuneration of auditors, and other special business. The document also references the Annual Report for FY 2024-2025 being sent electronically to members and available on the company's website and stock exchange websites. The content is typical of an AGM notice, which includes information about the meeting, resolutions to be passed, and procedural notes for shareholders. It is not the Annual Report itself, nor a financial statement or earnings release. It is a formal notice announcing the AGM and the business to be transacted there, including adoption of reports and dividend declaration. Therefore, the document fits the category of AGM Information (AGM-R).
2025-08-13 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains multiple notices related to Annual General Meetings (AGMs) of different companies, including details about the AGM dates, modes of holding the meetings (Video Conferencing/Other Audio Visual Means), record dates for dividends, e-voting information, and publication of newspaper advertisements for the AGMs. There is no detailed financial data, management discussion, or full report content. The document primarily consists of announcements and notifications about the AGM events and related shareholder information. Therefore, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or related announcements.
2025-08-12 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.